Aspiriant 13F: New $1M Stake in BIL

Aspiriant has initiated a new stake in the State Street SPDR Bloomberg 1-3 Month T-Bill ETF (BIL) by acquiring 11,000 shares valued at approximately $1,008,040, as disclosed in a filing on October 16, 2026. This reflects a fresh entry into the fund, which primarily invests in short-term U.S. Treasury securities with maturities ranging from one to three months.

What Changed in Aspiriant's Position

Aspiriant opened a new position with 11,000 shares in BIL, marking the beginning of its investment in this fund. The value of this new stake is about $1,008,040, indicating a strong belief in the stability of U.S. Treasury securities over the short term.

Other Institutional Activity in State Street SPDR BIL

B. Riley Wealth Advisors significantly increased its holdings in BIL just a few days prior, raising its stake by 444.5% to 513,880 shares. Additionally, on the same day as Aspiriant's filing, Concurrent Investment Advisors also boosted its investments in the ETF, demonstrating growing interest in U.S. Treasury securities among institutional investors.

State Street SPDR Bloomberg 1-3 Month T-Bill ETF Stock Holds Steady

The State Street SPDR Bloomberg 1-3 Month T-Bill ETF recently traded at around $91.57, which is slightly below its 52-week high of $91.77. The ETF is currently trading about equal to its 50-day and 200-day moving averages, indicating a stable price performance in the short term.

Recent Earnings

There are no recent earnings data available for this ETF, as it primarily tracks U.S. Treasury securities rather than operating as a traditional company with quarterly earnings reports.

Dividend

The ETF offers a dividend yield of 3.71%, reflecting its income-generating capability through U.S. Treasury investments.

Insider Buying and Selling at State Street SPDR Bloomberg 1-3 Month T-Bill ETF

There are no reported insider trading activities for the State Street SPDR Bloomberg 1-3 Month T-Bill ETF at this time.

Analysts Set New Price Targets

No recent analyst updates or price targets have been provided for BIL.

About State Street SPDR BIL

The State Street SPDR Bloomberg 1-3 Month T-Bill ETF invests primarily in short-term U.S. Treasury securities, focusing on those with maturities between one and three months. This strategy allows investors to gain exposure to government debt while managing interest rate risk. Aspiriant's new position suggests a strategic entry point into this relatively stable investment category.

Bottom Line

Investors should keep an eye on BIL's performance as it continues to attract institutional investors like Aspiriant and others who are looking for stability in their portfolios. The next key updates will likely come from the filings of other institutional players as the quarter progresses. Keep in mind that 13F filings are backward-looking: they show holdings as of the end of the reporting quarter and may not represent the fund's current position.